MYASTHENIA-GRAVIS AFTER BONE-MARROW TRANSPLANTATION - EVIDENCE FOR A DONOR ORIGIN

被引：110
作者：
SMITH, CIE
AARLI, JA
BIBERFELD, P
BOLME, P
CHRISTENSSON, B
GAHRTON, G
HAMMARSTROM, L
LEFVERT, AK
LONNQVIST, B
MATELL, G
PIRSKANEN, R
RINGDEN, O
SVANBORG, E
机构：
[1] HUDDINGE UNIV HOSP,BONE MARROW TRANSPLANT UNIT,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE UNIV HOSP,DEPT MED,DIV CLIN HEMATOL & ONCOL,S-14186 HUDDINGE,SWEDEN
[3] HUDDINGE UNIV HOSP,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN
[4] HUDDINGE UNIV HOSP,DEPT TRANSPLANTAT SURG,S-14186 HUDDINGE,SWEDEN
[5] KAROLINSKA INST,DEPT IMMUNOBIOL,S-10401 STOCKHOLM 60,SWEDEN
[6] UNIV BERGEN,DEPT NEUROL,N-5014 BERGEN,NORWAY
[7] SOUTH HOSP,CTR MYASTHENIA GRAVIS,STOCKHOLM,SWEDEN
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1983年 / 309卷 / 25期
关键词：
D O I：
10.1056/NEJM198312223092508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1565 / 1568
页数：4
相关论文
共 20 条
[1]   THYMOMA-SPECIFIC ANTIBODIES IN SERA FROM PATIENTS WITH MYASTHENIA-GRAVIS DEMONSTRATED BY INDIRECT HEMAGGLUTINATION [J].
AARLI, JA ;
LEFVERT, AK ;
TONDER, O .
JOURNAL OF NEUROIMMUNOLOGY, 1981, 1 (04) :421-427
[2]  
BODMER WF, 1977, HISTOCOMPATIBILITY T
[3]  
CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89
[4]   INFECTIOUS - MYASTHENIA [J].
DATTA, SK ;
SCHWARTZ, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (24) :1304-1305
[5]  
GROB D, 1981, ANN NY ACAD SCI, V377, P1
[6]  
Kissmeyer-Nielsen F., 1967, HISTOCOMPATIBILITY T, P381
[7]   DETERMINATION OF ACETYLCHOLINE-RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS - CLINICAL USEFULNESS AND PATHOGENETIC IMPLICATIONS [J].
LEFVERT, AK ;
BERGSTROM, K ;
MATELL, G ;
OSTERMAN, PO ;
PIRSKANEN, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1978, 41 (05) :394-403
[8]   DIFFERENCES IN THE INTERACTION OF ACETYLCHOLINE-RECEPTOR ANTIBODIES WITH RECEPTOR FROM NORMAL, DENERVATED AND MYASTHENIC HUMAN-MUSCLE [J].
LEFVERT, AK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1982, 45 (01) :70-73
[9]  
MINCHINTON RM, 1982, LANCET, V2, P627
[10]  
NAKAO Y, 1980, LANCET, V1, P677
12